Plasma levels of platinum-induced fatty acid [16:4n-3] do not affect response to platinum-based chemotherapy: A pilot study in non-small cell lung cancer patients.

Cancer shared this article with you from Inoreader Plasma levels of platinum-induced fatty acid [16:4n-3] do not affect response to platinum-based chemotherapy: A pilot study in non-small cell lung cancer patients. Via Clinical Lung Cancer CONCLUSIONS: This first of its kind study that evaluated plasma 16:4(n-3) in NSCLC patients showed that 16:4 (n-3) was elevated during FO supplementation, independent of fish oil supplementation or platinum-based chemotherapy. PMID: 33183547 [PubMed - in process] (Source: Clinical Lung Cancer) View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.